FRAZIER LIFE SCIENCES MANAGEMENT, L.P.
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | ERAS | 24.68M | $399.24M |
 | NAMS | 16.94M | $542.37M |
 | PHAT | 12.47M | $138.50M |
 | TRVI | 9.94M | $118.58M |
 | ARQT | 9.87M | $232.64M |
 | SVRA | 9.72M | $53.08M |
 | MIRM | 7.68M | $709.45M |
 | MBX | 6.65M | $198.56M |
 | MNKD | 5.90M | $14.46M |
 | AURA | 5.10M | $34.12M |
 | KALV | 4.96M | $99.87M |
 | ACRS | 4.93M | $18.47M |
 | MAZE | 4.57M | $136.33M |
 | AUTL | 4.45M | $6.14M |
 | LXEO | 4.42M | $25.40M |
 | BCRX | 4.01M | $38.17M |
 | ALLO | 3.80M | $9.26M |
 | BBIO | 3.45M | $256.06M |
 | DYN | 3.15M | $57.17M |
 | EOLS | 2.63M | $10.81M |
Erasca, Inc.
ERAS
Shares Held
24.68M
Value
$399.24M
NewAmsterdam Pharma Company N.V.
NAMS
Shares Held
16.94M
Value
$542.37M
Phathom Pharmaceuticals, Inc.
PHAT
Shares Held
12.47M
Value
$138.50M
Trevi Therapeutics, Inc.
TRVI
Shares Held
9.94M
Value
$118.58M
Arcutis Biotherapeutics, Inc.
ARQT
Shares Held
9.87M
Value
$232.64M
Savara Inc.
SVRA
Shares Held
9.72M
Value
$53.08M
Mirum Pharmaceuticals, Inc.
MIRM
Shares Held
7.68M
Value
$709.45M
MBX Biosciences, Inc. Common Stock
MBX
Shares Held
6.65M
Value
$198.56M
MannKind Corporation
MNKD
Shares Held
5.90M
Value
$14.46M
Aura Biosciences, Inc.
AURA
Shares Held
5.10M
Value
$34.12M
KalVista Pharmaceuticals, Inc.
KALV
Shares Held
4.96M
Value
$99.87M
Aclaris Therapeutics, Inc.
ACRS
Shares Held
4.93M
Value
$18.47M
Maze Therapeutics, Inc.
MAZE
Shares Held
4.57M
Value
$136.33M
Autolus Therapeutics plc
AUTL
Shares Held
4.45M
Value
$6.14M
Lexeo Therapeutics, Inc. Common Stock
LXEO
Shares Held
4.42M
Value
$25.40M
BioCryst Pharmaceuticals, Inc.
BCRX
Shares Held
4.01M
Value
$38.17M
Allogene Therapeutics, Inc.
ALLO
Shares Held
3.80M
Value
$9.26M
BridgeBio Pharma, Inc.
BBIO
Shares Held
3.45M
Value
$256.06M
Dyne Therapeutics, Inc.
DYN
Shares Held
3.15M
Value
$57.17M
Evolus, Inc.
EOLS
Shares Held
2.63M
Value
$10.81M